Logo image
Detection of Escherichia coli and associated β-lactamases genes from diabetic foot ulcers by multiplex PCR and molecular modeling and docking of SHV-1, TEM-1, and OXA-1 β-lactamases with clindamycin and piperacillin-tazobactam
Journal article   Open access   Peer reviewed

Detection of Escherichia coli and associated β-lactamases genes from diabetic foot ulcers by multiplex PCR and molecular modeling and docking of SHV-1, TEM-1, and OXA-1 β-lactamases with clindamycin and piperacillin-tazobactam

Shailesh K Shahi, Vinay K Singh and Ashok Kumar
PloS one, Vol.8(7), pp.e68234-e68234
2013
DOI: 10.1371/journal.pone.0068234
PMCID: PMC3701671
PMID: 23861873
url
https://doi.org/10.1371/journal.pone.0068234View
Published (Version of record) Open Access

Abstract

Diabetic foot ulcer (DFU) is a common and devastating complication in diabetes. Antimicrobial resistance mediated by extended-spectrum β-lactamases (ESBLs) production by bacteria is considered to be a major threat for foot amputation. The present study deals with the detection of Escherichia coli and the prevalence of bla(TEM), bla(SHV) and bla(OXA) genes directly from biopsy and swab of foot ulcers of diabetic patients. In total, 116 DFU patients were screened, of which 42 suffering with severe DFUs were selected for this study. Altogether 16 E. coli strains were successfully isolated from biopsy and/or swab samples of 15 (35.71%) patients. ESBL production was noted in 12 (75%) strains. Amplification of β-lactamase genes by multiplex PCR showed the presence of bla(CTX-M) like genes in 10 strains, bla(TEM) and bla(OXA) in 9 strains each, and bla(SHV) in 8 of the total 16 strains of E. coli. Out of the ten antibiotics tested, E. coli strains were found to be resistant to ampicillin (75%), cefoxitin (56.25%), cefazolin (50%), meropenem (37.5%), cefoperazone (25%), cefepime (31.25%), ceftazidime (56.25%), and cefotaxime (68.75%) but all showed sensitivity (100%) to clindamycin and piperacillin-tazobactam. 3D models of the most prevalent variants of β-lactamases namely TEM-1, SHV-1, OXA-1, and ESBL namely CTX-M-15 were predicted and docking was performed with clindamycin and piperacillin-tazobactam to reveal the molecular basis of drug sensitivity. Docking showed the best docking score with significant interactions, forming hydrogen bond, Van der Waals and polar level interaction with active site residues. Findings of the present study may provide useful insights for the development of new antibiotic drugs and may also prevent ESBLs-mediated resistance problem in DFU. The novel multiplex PCR assay designed in this study may be routinely used in clinical diagnostics of E. coli and associated bla(TEM), bla(SHV), and bla(OXA) like genes.
Anti-Bacterial Agents - chemistry Anti-Bacterial Agents - pharmacology beta-Lactam Resistance - drug effects beta-Lactamase Inhibitors beta-Lactamases - chemistry beta-Lactamases - genetics beta-Lactams - chemistry beta-Lactams - pharmacology Clindamycin - chemistry Clindamycin - pharmacology Diabetic Foot - complications Diabetic Foot - drug therapy Diabetic Foot - microbiology Escherichia coli - drug effects Escherichia coli - enzymology Escherichia coli - genetics Escherichia coli - isolation & purification Escherichia coli Infections - complications Escherichia coli Infections - drug therapy Escherichia coli Infections - microbiology Gene Expression Humans Microbial Sensitivity Tests Molecular Docking Simulation Multiplex Polymerase Chain Reaction Penicillanic Acid - analogs & derivatives Penicillanic Acid - chemistry Penicillanic Acid - pharmacology Piperacillin - chemistry Piperacillin - pharmacology Structural Homology, Protein Structure-Activity Relationship

Details

Metrics

Logo image